| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. | Chief Business Officer | Common Stock | 136K | $1.65M | $12.06 | Dec 13, 2024 | Direct |
| ARS Pharmaceuticals, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 55.5K | Dec 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Dec 12, 2024 | 6 | -$1.63M | 4 | Dec 13, 2024 | Chief Business Officer |
| SPRY | ARS Pharmaceuticals, Inc. | Dec 10, 2024 | 3 | -$616K | 4 | Dec 12, 2024 | Chief Business Officer |
| SPRY | ARS Pharmaceuticals, Inc. | Dec 4, 2024 | 9 | -$1.92M | 4 | Dec 6, 2024 | Chief Business Officer |
| SPRY | ARS Pharmaceuticals, Inc. | Dec 2, 2024 | 8 | -$1.13M | 4 | Dec 4, 2024 | Chief Business Officer |
| SPRY | ARS Pharmaceuticals, Inc. | Nov 25, 2024 | 3 | -$1.41M | 4 | Nov 27, 2024 | Chief Business Officer |
| SPRY | ARS Pharmaceuticals, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Chief Business Officer |
| SPRY | ARS Pharmaceuticals, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Chief Business Officer |
| SPRY | ARS Pharmaceuticals, Inc. | Nov 8, 2022 | 5 | $0 | 4 | Nov 10, 2022 | Chief Business Officer |
| SPRY | ARS Pharmaceuticals, Inc. | Nov 8, 2022 | 0 | $0 | 3 | Nov 10, 2022 | Chief Business Officer |